FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients
Weight-loss drug Wegovy approved to reduce cardiovascular risk in overweight patients.
Wegovy can lower the risk of heart attacks, strokes, and heart-related deaths in patients with obesity.